Cargando…
Guiding axes for drug safety management of pharmacovigilance centres during the COVID-19 era
The COVID-19 pandemic presents several challenges to the organisation and workflow of pharmacovigilance centres as a result of the massive increase in reports, the need for quick detection, processing and reporting of safety issues and the management of these within the context of lack of complete i...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170628/ https://www.ncbi.nlm.nih.gov/pubmed/34076805 http://dx.doi.org/10.1007/s11096-021-01289-0 |